CH EPL (R5)
1.0.0-ci-build - ci-build Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Reimbursement SL 21203 1 Pre-Filled Pen

CH - EPL Reimbursement SL

  • FOPHDossierNumber: FOPH Dossier Number/21203
  • status: Reimbursed
  • statusDate: 2021-06-01
  • expiryDate: 9999-12-31
  • listingStatus: Listed
  • listingPeriod: 2021-06-01 --> 9999-12-31
  • firstListingDate: 2021-06-01
  • costShare: 10
  • productType: Originator product
  • gamme: Parenteral

CH - EPL Product Price

  • value: CHF371.10 (CHF)
  • type: Ex-factory price
  • changeType: Normal price mutation
  • changeDate: 2023-12-01

CH - EPL Product Price

  • value: CHF419.95 (CHF)
  • type: Retail price
  • changeType: VAT-change
  • changeDate: 2023-12-01

subject: PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7601001010604-6783101-001; containedItemQuantity = 1 Pre-filled pen; description = ABRILADA Inj Lös 40 mg/0.8ml Fertpen 1 x 0.8 ml

type: Reimbursement SL

Indications

-ExtensionReference
*, , , , , , ClinicalUseDefinition: type = indication

holder: Organization Pfizer AG

Generated Narrative: Organization #holder-Pfizer-AG

identifier: LOC Identifier/100015286, GLN Identifier/7601001010604

name: Pfizer AG